Poteligeo (Mogamulizumab-Kpkc)
4 mg/mL · Injection
By Kyowa Kirin, Inc.
Mogamulizumab-Kpkc · Injection · 4 mg/mL · IV
- NDC
- 42747-761
- Route
- Intravenous
- Therapeutic class
- Antibodies, Monoclonal [CS], Chemokine Receptor Type 4 Interaction , Chemokine Receptor Type 4 Interactions [MoA], Monoclonal Antibody
- Marketing category
- BLA
Package sizes
- 1 VIAL, GLASS in 1 CARTON (42747-761-01) / 5 mL in 1 VIAL, GLASSNDC 42747-761-01Available to Order
Request This Medication
*Expect a reply within 2 business hours with availability and pricing.
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request a quote
Request this medication.
Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.
- DSCSA-compliant pedigree on every order
- Cold-chain capable where applicable
- Same-day fulfillment available for urgent needs
Related in Oncology & Specialty
See all →Verzenio (Abemaciclib)
50 mg/1 · Tablet
Eli Lilly and Company
Available to Source
Verzenio (Abemaciclib)
200 mg/1 · Tablet
Eli Lilly and Company
Available to Source
Verzenio (Abemaciclib)
100 mg/1 · Tablet
Eli Lilly and Company
Available to Source
Verzenio (Abemaciclib)
150 mg/1 · Tablet
Eli Lilly and Company
Available to Source
